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Abstract
The PR interval on the electrocardiogram reflects atrial and atrioventricular nodal conduction time. The PR interval is
heritable, provides important information about arrhythmia risk, and has been suggested to differ among human races.
Genome-wide association (GWA) studies have identified common genetic determinants of the PR interval in individuals of
European and Asian ancestry, but there is a general paucity of GWA studies in individuals of African ancestry. We performed
GWA studies in African American individuals from four cohorts (n = 6,247) to identify genetic variants associated with PR
interval duration. Genotyping was performed using the Affymetrix 6.0 microarray. Imputation was performed for 2.8 million
single nucleotide polymorphisms (SNPs) using combined YRI and CEU HapMap phase II panels. We observed a strong signal
(rs3922844) within the gene encoding the cardiac sodium channel (SCN5A) with genome-wide significant association
(p,2.561028) in two of the four cohorts and in the meta-analysis. The signal explained 2% of PR interval variability in
African Americans (beta = 5.1 msec per minor allele, 95% CI = 4.1–6.1, p = 3610223). This SNP was also associated with PR
interval (beta = 2.4 msec per minor allele, 95% CI = 1.8–3.0, p = 3610216) in individuals of European ancestry (n = 14,042), but
with a smaller effect size (p for heterogeneity ,0.001) and variability explained (0.5%). Further meta-analysis of the four
cohorts identified genome-wide significant associations with SNPs in SCN10A (rs6798015), MEIS1 (rs10865355), and TBX5
(rs7312625) that were highly correlated with SNPs identified in European and Asian GWA studies. African ancestry was
associated with increased PR duration (13.3 msec, p = 0.009) in one but not the other three cohorts. Our findings
demonstrate the relevance of common variants to African Americans at four loci previously associated with PR interval in
European and Asian samples and identify an association signal at one of these loci that is more strongly associated with PR
interval in African Americans than in Europeans.
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Introduction
The electrocardiogram is an important clinical tool that provides a
graphical representation of the electrical activity of the heart as
captured by skin surface electrodes. The electrocardiographic PR
interval represents conduction through the atria and AV node, and
impaired conduction through these tissues is a central pathogenic
mechanism in many cardiac arrhythmias. Prolongation of the PR
interval is a risk factor for long-term atrial fibrillation, heart block, and
all-cause mortality [1]. A substantial proportion of the variability of
the PR interval is explained by genetic factors with heritability
estimates ranging between 30 and 50% in populations of European
and Asian ancestry [2–7]. Identification of the specific alleles
underlying the heritability of the PR interval might provide novel
insights into molecular electrophysiology, lead to novel drug targets
for arrhythmia treatment, and facilitate genetic prediction of
arrhythmia risk and response to antiarrhythmics. Genome-wide
association (GWA) studies have identified nine loci associated with
PR interval duration in populations of European [6,8] or South Asian
ancestry [9]. Four of these associations have been replicated [6,9].
However, there is a general paucity of GWA studies performed in
populations of African ancestry [10] and none have been performed
for PR interval duration which has been suggested to be longer in
individuals of African than European ancestry [11]. Samples of
African ancestry typically have shorter-range linkage disequilibrium
(LD) than samples of European or Asian ancestry, potentially
reducing genomic coverage in GWA studies using fixed arrays.
However, samples of African ancestry offer greater genetic diversity;
European and Asian populations have experienced a loss of allelic
diversity since the out-of-Africa founding events [12,13]. Thus,
unique alleles influencing complex traits may be present in samples of
African ancestry and shorter-range LD can facilitate narrowing of
association signals.We studied the association of genetic ancestry with
PR interval and performed a GWA study in 6,247 African Americans
from four cohorts as part of the Candidate-gene Association Resource
(CARe) consortium including the Atherosclerosis Risk in Commu-
nities (ARIC) study, the Cleveland Family Study (CFS), the Jackson
Heart Study (JHS) and the Multi-Ethnic Study of Atherosclerosis
(MESA). Replication of genome-wide significant associations was
attempted by direct genotyping in 2,022 African Americans from the
Health, Aging, and Body Composition Study (Health ABC) and the
Healthy Aging in Neighborhoods of Diversity across the Life Span
Study (HANDLS).
Results
Phenotype modeling
Baseline characteristics of the study populations are shown in
Table 1. After adjustment for covariates, residual standard
deviations for PR interval ranged from 22.1 to 26.9 msec in the
four cohorts. The proportion of variation in phenotype explained
by covariates (r2) was modest, ranging from 0.04 to 0.15, as shown
in Table 1.
Genetic ancestry and PR interval
The distribution of European ancestry relative to African
ancestry was similar across cohorts; ARIC (median 0.15, IQR
0.11–0.22), CFS (median 0.18, IQR 0.13–0.26), JHS (median
PR Duration GWAS in African Americans
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0.16, IQR 0.12–0.21) and MESA (median 0.19, IQR 0.12–0.30).
African ancestry was associated with longer PR interval than
European ancestry in ARIC (13.3 msec longer for complete
African compared to complete European ancestry, p= 0.009) but
not in CFS (213.2 msec, p= 0.44), JHS (1.0 msec, p = 0.89) or
MESA (7.2 msec, p = 0.11).
Meta-analysis of genome-wide association studies
Genomic inflation was minimal in ARIC (lGC=1.02) and
MESA (lGC=1.01) and modest in the family-based CFS
(lGC=1.10) and JHS (lGC=1.08) studies, likely due to relatedness
of some participants. Quantile-quantile plots of p-values were
consistent with null distributions at all but the lowest p-values
(Figure S1). Genomic control was applied to test statistics in all
cohorts. Genomic inflation in the meta-analysis was modest
(lGC=1.04); genomic control was applied again (Figure 1). The
distribution of association results across the genome is shown in
Figure 2. Twenty-four single nucleotide polymorphisms (SNPs) at
four genomic loci reached genome-wide significance as shown in
Table S1. We clustered these SNPs by pairwise correlation in the
HapMap phase II YRI panel and observed five weakly correlated
linkage disequilibrium bins (all pairwise r2 were ,0.3). Results for
the SNP with the lowest p-value in each cluster are shown in
Table 2 and the correlation of these SNPs to SNPs reported in
previous GWA studies of European and Asian ancestry are shown
in Table 3.
The top association result was for rs3922844 at SCN5A (5.1
msec per minor allele, 95% CI=4.1–6.1, p = 3610223), explain-
ing 2% of variation in PR interval. The SNP (rs3922844) reached
genome-wide significance (p,2.561028) in the larger cohorts,
ARIC and JHS, considered individually. The SNP had a large
effect estimate (5.1–6.1 msec or 0.19–0.24 standard deviations per
C-allele) consistently across ARIC, JHS and MESA as shown in
Table 2. The effect estimate was smaller in CFS, but CFS had a
smaller sample of African Americans and hence wider confidence
intervals than was observed in other larger samples. We observed
no evidence of heterogeneity across the four African American
cohorts (p for heterogeneity = 0.41). The SNP was well imputed in
all cohorts as shown in Table S2. It was not correlated in HapMap
CEU or YRI panels with the SNPs at this locus that have been
identified in previous GWA studies of European or Asian ancestry
(r2,0.10, Table 3).
We observed an additional association signal in SCN5A
(rs6599222, p = 261028), for which the strongest SNP was in
LD with the SNP identified in a previous European GWA study
(rs11708996, r2 = 0.61) and with an effect size (+3.4 msec per
minor allele, 95%CI= 2.2–4.6) that was similar to the EuropeanTable 1. Description of African American study samples.
ARIC CFS JHS MESA
Age (years) 53.2
(8.8)
44.3
(15.2)
49.3
(11.7)
62.1
(10.1)
Sex (% male) 38.1% 42.2% 38.7% 45.5%
Body mass index (kg/m2) 29.5
(6.1)
34.5
(9.2)
32.3
(7.8)
30.2
(5.9)
Height (cm) 168.1
(9.0)
168.9
(9.9)
169.7
(9.4)
168.4
(9.6)
Systolic blood pressure (mm Hg) 128.1
(20.7)
126.1
(14.4)
124.6
(17.8)
131.6
(21.6)
RR duration (msec) 923.0
(149.8)
902.6
(131.4)
948.8
(148.2)
975.4
(154.9)
PR duration (msec) 172.4
(27.5)
169.0
(25.7)
170.6
(26.0)
170.8
(26.0)
PR sd (msec) 26.9 22.1 25.4 25.1
PR coefficient of determination 0.04 0.15 0.05 0.07
Sample size 2391 267 1962 1627
Mean and standard deviations are presented for continuous measures and
percentages for categorical variables. PR sd refers to standard deviation of PR
interval after covariate adjustment. lGC refers to the genomic inflation factor. PR
coefficient of determination refers to the proportion of variability explained by
covariates in the model (age, sex, RR interval, body mass index, height, systolic
blood pressure and study site where relevant).
doi:10.1371/journal.pgen.1001304.t001
Figure 1. Quantile-quantile plot for meta-analysis of genome-
wide association studies of PR interval duration in African
Americans. Plotted on the x-axis are expected p-values under the null
hypothesis and on the y-axis the observed p-values after genomic
control has been applied.
doi:10.1371/journal.pgen.1001304.g001
Author Summary
We performed genome-wide association studies in African
American participants from four population-based cohorts
to identify genetic variation that correlates with variation
in PR interval duration, an electrocardiographic measure of
conduction through the atria and atrioventricular node.
We observed a strong signal within the gene encoding the
cardiac sodium channel, SCN5A, with genome-wide
significant association (p,2.561028) in two cohorts and
in a meta-analysis of four cohorts with African Americans.
We replicated this association in two additional cohorts of
African Americans and in Europeans (p = 3610216). The
signal explains 2% of PR duration variability in African
Americans and 0.5% in Europeans. In further meta-analysis,
we observed genome-wide significant associations for
single nucleotide polymorphisms in SCN10A, MEIS1, TBX5,
corresponding to signals observed in people of European
and Asian descent. We found an association of genetic
ancestry and PR interval in one but not the other three
cohorts. Our findings provide the first demonstration of
the relevance of these loci to individuals of African
ancestry and identify an association signal from SCN5A
that is more strongly associated with PR interval in African
Americans.
PR Duration GWAS in African Americans
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study [8]. However, when analyzed conditional on rs3922844, the
SNP rs6599222 was only borderline significantly associated with
PR interval as shown in Table S3. The SNPs in SCN5A previously
reported to be associated with PR interval in a cohort of
Micronesians [5] were not associated with PR interval in African
Americans (p = 0.57). The association results, correlations and
locations of all studied SNPs in SCN5A are plotted against
recombination rates in Figure 3.
We further observed significant associations for a cluster of ten
highly correlated SNPs in SCN10A that included the missense SNP
(rs6795970) reported previously in GWA studies of individuals of
European and Asian ancestry [6,8,9]. The missense SNP did not
have the lowest p-value in the cluster but had the highest effect
estimate, the lowest minor allele frequency (Table 2) and a
somewhat lower imputation quality than other SNPs. Significant
associations also were seen with SNPs inTBX5 and MEIS1. These
correlated with the strongest reported SNPs from the GWA study
performed in individuals of European ancestry at the loci shown in
Table 3. The SNPs with the lowest p-values in each cluster were
all well imputed as shown in Table S2. We observed no evidence
for heterogeneity of effect across cohorts for any SNP reported in
Table 2 (p.0.05).
As shown in Table 4, additional adjustment for local ancestry
estimates did not impact any of the genome-wide significant
associations.
Of the other SNPs reaching genome-wide significance in
previous studies [6,8], rs3807989 in CAV1 showed some evidence
of association in the same direction (2.1 msec per A allele,
p = 661025) as did rs7692808 (21.7 msec per A allele, p = 0.004)
and rs7660702 (21.2 msec per C allele, p = 0.02) in ARHGAP24
but not rs251253 near NKX2-5 (p = 0.98), rs4944092 in WNT11
(p = 0.93) or rs11047543 in SOX5 (p = 0.20).
Figure 2. PR interval association results for 2.8 million SNPs across 22 autosomes. Each dot represents one SNP. Plotted on the x-axis is
physical position by chromosome and on the y-axis –log10(p-value).
doi:10.1371/journal.pgen.1001304.g002
Table 2. SNPs with the lowest p-values in each cluster of SNPs reaching genome-wide significance (p,2.561028).
SNP Gene Position Allele CAF ARIC CFS JHS MESA Neff Meta-analysis Q I
2
Beta
(SE) P
Beta
(SE) P
Beta
(SE) P
Beta
(SE) P Beta (SE) P
rs3922844 SCN5A Chr3:38,
599,257
C/T 0.41 5.08
(0.85)
261029 0.91
(2.58)
0.72 6.14
(0.90)
7610212 4.57
(0.94)
161026 5726 5.11
(0.51)
3610223 p = 0.41 0.25
rs6798015 SCN10A Chr3:38,
773,840
C/T 0.14 4.04
(1.18)
661024 6.31
(3.23)
0.05 5.43
(1.25)
161025 5.41
(1.28)
261025 6080 4.98
(0.70)
2610212 p = 0.81 0
rs10865355 MEIS1 Chr2:66,
618,501
A/G 0.43 2.55
(0.79)
0.001 3.64
(2.32)
0.11 3.40
(0.87)
961025 2.67
(0.89)
0.003 6247 2.89
(0.48)
361029 p = 0.93 0.46
rs7312625 TBX5 Chr12:113,
284,357
A/G 0.71 22.27
(0.92)
0.01 23.71
(2.60)
0.15 24.11
(0.97)
261025 23.34
(1.02)
0.001 5718 23.23
(0.55)
761029 p = 0.67 0
rs6599222 SCN5A Chr3:38,
623,066
C/T 0.23 3.24
(0.99)
0.001 20.67
(3.02)
0.83 4.38
(1.06)
461025 3.07
(1.13)
0.007 5616 3.40
(0.61)
261028 p = 0.99 0
Positions refer to NCBI build 36. Alleles refer to coded/noncoded. CAF refers to the coded allele frequency in the pooled samples. Neff refers to the effective sample size
in the meta-analysis, defined as N6R2, and reflects the loss of power with poor imputation compared to the total sample size shown in the first row. Beta coefficients
per coded allele and p-values are given per cohort and for the meta-analysis. Genomic control has been applied in all samples. For heterogeneity, Q refers to the p-value
from Cochran’s Q test and I2 refers to the I2 statistic. All five SNPs are intronic.
doi:10.1371/journal.pgen.1001304.t002
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Replication in African Americans
The strongest SNPs at loci reaching genome-wide significance
were genotyped in Health ABC and HANDLS. As shown in Table 4,
we observed evidence of replication for the top SNPs in SCN5A,
SCN10A andMEIS1 and borderline significant replication for TBX5.
Association study in individuals of European ancestry
We examined the result for rs3922844 in a large, European
GWA study (CHARGE-PR) [8], where it was imputed in four
cohorts (n = 14,042). We observed a significant association with
the PR interval (beta 2.40 msec per major allele, 95% CI= 1.83–
2.97, p = 3610216). As in HapMap reference panels, allele
frequencies were reversed in Europeans compared to African
Americans, with a minor allele frequency of 0.30 for the T-allele.
The effect size was significantly different in CHARGE-PR as
compared to CARe (p for heterogeneity ,0.001, I2 = 0.99).
Discussion
We performed a meta-analysis of GWA studies of the PR
interval duration in individuals of African ancestry from four
cohorts. We used a stringent significance threshold of 2.561028,
as previous genetic analyses have suggested twice as many
independent SNPs in samples of African ancestry compared to
European ancestry [14].
In two cohorts and in the meta-analysis we observed a genome-
wide significant association with the SNP rs3922844 in SCN5A that
explains approximately 2% of variability in PR interval duration.
The SNP was not correlated with rs11708996, another SNP in
SCN5A associated with PR interval duration in prior GWA studies
of subjects of European ancestry [8], and had a larger effect
estimate than rs11708996. We, therefore, examined the result for
rs3922844 in a previously reported GWA study of PR interval in
subjects of European ancestry [8] and observed genome-wide
significant association but with a smaller effect estimate as
compared to our study (5.1 msec, 95% CI= 4.1–6.1 versus 2.4
msec, 95% CI= 1.8–3.0, p for heterogeneity ,0.001).Thus, we
have evaluated genetic variants associated with PR interval
duration in subjects of African American ancestry and identified
an association signal from SCN5A with a larger effect size in
individuals of African American compared to European ancestry.
We consider direct prolongation of the PR interval by
rs3922844 unlikely given the differing effect sizes in individuals
of African American and European ancestry. No SNP catalogue,
including HapMap, used as reference panel for imputation in our
study, includes all common sequence variants. We consider it
more likely that rs3922844 is correlated with one or several causal
variants and that the varying effect sizes result from differences in
LD patterns across populations. For example, two variants with
opposing effects could exist at the locus, with overlapping signals in
Europeans but with isolation of individual signals in African
Americans due to breakdown of linkage disequilibrium. The SNP
rs3922844 was not directly genotyped in our samples but was
imputed with high imputation quality as measured by the average
ratio of observed variance to that expected by the Hardy-
Weinberg equilibrium. We note that no SNPs included on our
genotyping platform had an r2.0.2 with rs3922844 in the African
(YRI) HapMap panel. A small cluster of genotyped SNPs were
well correlated with rs3922844 in the European (CEU) HapMap
panel (r2 = 0.6–0.8) as shown in Figure 3 but none of these reached
a p-value less than 1024. These observations suggest that the
association was detected due to correlation of rs3922844 with
multiple, weakly correlated, genotyped SNPs. Alternatively, a
strong gene-environment interaction for rs3922844 could result in
large differences in effect estimates across populations subject to
differential environmental exposures or other genetic effects.
Large-scale resequencing or imputation from large-scale resequen-
cing efforts such as the 1000 Genomes Project, and functional
experiments will ultimately be necessary to identify the causal
variants.
Although allelic heterogeneity between families is well estab-
lished for monogenic diseases, little is known about common
variants across different populations. Recently identified findings
include different association signals at the locus containing KCNQ1
with type 2 diabetes in European and Asian cohorts [10], atMYH9
with focal segmental glomerulosclerosis [15] and a MYBPC3
variant that causes cardiomyopathy and is only polymorphic in
Asian populations [16]. Allelic heterogeneity is conceptually
important and highlights the value of genetic association studies
spanning diverse racial and ethnic populations. Studies across
multiple populations may identify novel disease loci and genetic
factors underlying differences in risk by race. Our results do not
Table 3. Correlation of the SNPs with the lowest p-value in each cluster of SNPs reaching genome-wide significance in CARe to
SNPs reaching genome-wide significance in previous European and Asian studies.
CARe SNP Locus
SNP in previous
studies Reference CEU r2 YRI r2 ASW r2 LWK r2 MKK r2
rs3922844 SCN5A rs11708996
rs7638909
Pfeufer 2009
Smith 2009
0.09
0.04
Mono
0.004
N/A
0.03
N/A
0.006
N/A
0.01
rs6798015 SCN10A rs6795970
rs6795970
rs6800541
Chambers 2009 Holm
2009 Pfeufer 2009
0.72
aaa
0.75
0.19
aaa
0.19
0.40
aaa
0.40
0.36
aaa
0.36
0.48
0.51
rs10865355 MEIS1 rs11897119 Pfeufer 2009 1.00 0.59 0.78 0.71 0.86
rs7312625 TBX5 rs1896312
rs3825214
Pfeufer 2009
Holm 2009
-
0.70
-
0.42
-
0.59
-
0.44
-
0.20
rs6599222 SCN5A rs11708996
rs7638909
Pfeufer 2009
Smith 2009
0.61
0.07
Mono
0.003
N/A
,0.001
N/A
0.04
N/A
0.008
Correlations were examined in the following samples from HapMap phase II (release 22) or HapMap phase III (release 2): CEU – Utah residents with northern and
western European ancestry from the CEPH collection, YRI – Yoruba in Ibadan, Nigeria, ASW – African ancestry in southwestern USA, LWK – Luhya in Webuye, Kenya, MKK
– Maasai in Kinyawa, Kenya. The strongest SNP in SCN5A in European studies (rs11708996) is monomorphic in YRI and was not genotyped in HapMap phase III. The SNP
downstream of TBX5 described in Pfeufer et al is .500 kb from the other two SNPs, that are located within the gene. The correlation of the two previously described
SNPs in SCN10A is 0.97 in CEU. The correlation of our two SNPs in SCN5A is 0.001 in CEU, 0.27 in YRI, 0.19 in ASW, 0.03 in LWK and 0.05 in MKK.
doi:10.1371/journal.pgen.1001304.t003
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provide support for allelic heterogeneity across populations for PR
interval, although limited power may have failed to detect such
effects.
Genetic admixture studies have estimated that, on average,
modern African American genomes have approximately 80–90%
African and 10–20% European ancestry [17], which is well in line
with our global ancestry analyses. It is important to note that there
is great genetic diversity across the African continent. Our study
included African Americans, who predominantly have an
ancestral origin in Central and West Africa. It is possible that
GWA studies in other samples of African ancestry might identify
additional association signals.
The clinical impact of our findings merit further exploration. For
example, a missense variant in SCN5A, S1103Y (rs7626962), which is
polymorphic in African Americans but very rare in Europeans, has
been associated with a markedly increased risk of ventricular
arrhythmias [18]. This variant was not correlated with rs3922844
in the YRI panel of HapMap phase III (r2=0.04). Furthermore,
African Americans have been shown to have a lower incidence of
atrial fibrillation than Europeans. Longer PR interval duration
(difference in means 11.8 msec) has also been reported in African
Americans compared to Europeans in the ARIC study [11]. We were
able to confirm this observation in ARIC using genetic ancestry, with
a similar magnitude (13.3 msec longer with complete African
compared to complete European ancestry, p=0.009). However, we
did not observe differences by genetic ancestry in CFS, JHS or
MESA. This discrepancy could be due to differences in trans-African
ancestry or other factors. Our results further indicate that common
variants are unlikely to explain a large part of any ancestry-related
variation in atrial and atrioventricular nodal conduction. The
strongest variant observed here explained 2% of PR interval
variability. It seems more likely that any ancestry-related differences
in atrial conduction are due to rare variants, but this awaits further
testing. Additional studies in populations with atrial fibrillation or
sudden cardiac death will be necessary to determine the impact of the
SNPs identified in our study on clinical outcomes.
In our meta-analysis, we also observed genome-wide significant
association signals of SNPs in SCN10A, TBX5 and MEIS1, which
are correlated with SNPs reported in previous GWA studies in
individuals of European ancestry. The lowest p-value in the
SCN10A cluster of SNPs was not observed in the previously
described missense variant (rs6795970) [6,9] but in an intronic
SNP (rs6798015). The effect estimate was highest for the missense
SNP but it also had the lowest minor allele frequency in the
cluster, a lower allele frequency than in European (CEU) and
Figure 3. Regional association plots for PR interval duration at
the SCN5A locus. The plot covers the genomic region from 100 kb
upstream of SCN5A to 100 kb downstream of SCN5A. White diamonds
represent genotyped SNPs and grey diamonds represent imputed SNPs.
The large blue diamond represents the SNP with the lowest p-value
(rs3922844). Diamond color represents pairwise correlation between
directly genotyped SNPs with the strongest SNP; red indicates strong
correlation (r2.0.8), orange indicates moderate correlation
(0.8.r2.0.5) and yellow indicates weak correlation (0.5.r2.0.2).
Recombination rate is plotted in the background and known genes
are shown in the bottom of the plot. Positions refer to NCBI build 36.
SNP correlations and estimates of recombination rates were obtained
from HapMap phase II. Panel A uses LD patterns from the YRI sample
and Panel B from the CEU sample for results in individuals of African
American ancestry.
doi:10.1371/journal.pgen.1001304.g003
Table 4. Replication and local ancestry analyses of SNPs with the lowest p-value in each cluster of SNPs reaching genome-wide
significance.
CARe SNP Locus Local ancestry Replication
ARIC CFS JHS MESA Meta-analysis
rs3922844 SCN5A 4.80 (0.87),
p = 3610-8
0.30 (2.52), p = 0.90 6.30 (0.89),
p = 1610212
3.67 (0.98),
p = 261024
p = 7610221 p = 761027
rs6798015 SCN10A 3.42 (1.24),
p = 0.006
5.93 (3.29), p = 0.07 5.72 (1.28),
p = 861026
4.08 (1.34),
p = 0.002
p = 7610210 p = 0.0002
rs10865355 MEIS1 2.57 (0.79),
p = 0.001
3.61 (2.22), p = 0.10 3.45 (0.83),
p = 461025
2.64 (0.88),
p = 0.003
p = 5610210 p = 0.007
rs7312625 TBX5 22.27 (0.91),
p = 0.01
23.63 (2.48), p = 0.14 24.13 (0.93),
p = 161025
23.34 (1.01),
p = 0.001
p = 161029 p = 0.05
Results refer to inverse variance weighted meta-analyses of CARe cohorts adjusted for local ancestry estimates and for replication by direct genotyping in Health ABC
and HANDLS cohorts. For local ancestry analyses, beta (standard error) and p-values are shown.
doi:10.1371/journal.pgen.1001304.t004
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Asian (JPT and CHB) HapMap panels. No evidence that the
missense variant explains the association with PR interval has been
published yet. Although it is possible that another SNP mediates
the association, we find it more likely that the weaker p-value for
the intronic SNP in our meta-analysis reflects differences in
imputation quality or chance difference in the strength of the
observed association. To ultimately identify the causal variants in
each population, large-scale resequencing and functional experi-
ments will be necessary.
Four genome-wide association studies for PR interval duration
have been published previously. The first study identified an
association with SNPs in SCN5A in a Micronesian founder
population, but no SNP reached genome-wide significance [5]. A
large study in individuals of European ancestry identified nine loci
of genome-wide significance [8], including ARHGAP24, CAV1/
CAV2, MEIS1, NKX2-5, SCN5A, SCN10A, SOX5, TBX5/TBX3 and
WNT11. A third study in Icelanders identified and replicated
significant associations with four of these loci [6]; ARHGAP24,
CAV1, SCN10A and TBX5/TBX3. Finally, a study in individuals of
Asian ancestry identified and replicated association with SNPs in
SCN10A [9]. Here, we have reported genome-wide significant
associations in African Americans with SNPs in strong LD with the
previously reported SNPs at four of these loci; MEIS1, SCN5A,
SCN10A and TBX5/TBX3. These findings demonstrate the
relevance of these common alleles to individuals of African ancestry.
Our study has a number of limitations. All GWA studies suffer
risk of false positive associations due to multiple testing, which is
higher in samples of African ancestry where two million
independent SNPs have been described [14]. We therefore
applied a stringent significance threshold (2.561028) to account
for the approximately two million common variant tests estimated
to exist across the genome. Large sample sizes are required to
achieve such stringent significance levels. Our significant findings
are thus unlikely to be false positives, especially as association
signals at the same loci have been observed in European studies.
However, even in the meta-analysis our study was underpowered
to detect both common variants of small effect and rare variants.
Measurement error in PR duration and heterogeneity between
cohorts may further contribute to loss of power. Another potential
problem encountered in genetic association studies is population
stratification or confounding by ancestry. We sought to address
this issue by filtering out individuals with cryptic relatedness or
unlikely to be of African ancestry, adjusting for principal
components of genome-wide data that describe within-population
genetic variation, using family-based methods where appropriate
and applying genomic control.
In conclusion, our results suggest that genetic loci underlying
complex traits may be in large part the same across ancestral
populations. However, association signals may show different
effects across ethnic and racial populations and multiple
association signals may exist at these loci. We anticipate that
large-scale resequencing and functional experiments will ultimate-
ly identify the causal variants specific to each population.
Materials and Methods
Ethics statement
The study was approved by the Institutional Review Board at all
participating institutions. Only individuals who provided informed
consent to genetic testing were included.
Study samples
Individuals of self-reported African American ancestry from
four cohort studies were genotyped as part of the Candidate-gene
Association Resource (CARe) [19] (Lettre G et al, submitted).
Detailed descriptions of these cohorts have been published
previously [20–23]. Additional details are shown in Table S4.
Details on replication samples (Health ABC, HANDLS) are shown
in Table S5.
ARIC. The Atherosclerosis Risk in Communities (ARIC)
study is a prospective population-based study of atherosclerosis
and cardiovascular disease that included 15,792 men and women
between 45 and 64 years from four US communities, 4,314 of
whom were self-reported black Americans from two of the four
communities (Jackson, MS and Forsyth County, NC) [20].
Electrocardiographic recordings used in the present study were
performed at baseline examinations between 1987–1989. After
exclusions, data on 2,391 black individuals with genotypes,
information on all covariates and informed consent remained for
analyses.
CFS. The Cleveland Family Study (CFS) is a family-based,
longitudinal study designed to study the risk factors for sleep apnea
[21]. The 632 African Americans with available DNA were
genotyped as part of CARe. Electrocardiographic recordings used
for the present study were performed at the final exam cycle
conducted in a Clinical Research Unit between 2001–2006. After
exclusions, 267 individuals remained for analyses.
JHS. The Jackson Heart Study (JHS) is a prospective,
community-based study of the causes of the high prevalence of
cardiovascular disease in African Americans that includes 5,301
self-reported African Americans recruited between 2000–2004
[22]. The cohort comprises residents of a tri-county area near
Jackson, MS (Hinds County, Rankin County and Madison
County). The study includes a subsample of unrelated
participants (35–84 years) and a nested family-based subcohort
($21 years). Electrocardiographic recordings used in the present
study and blood collection for DNA extraction were performed at
baseline examinations between 2000–2004. Genotype data were
available in 3,030 individuals, including 885 who were also
included in the ARIC study. After exclusions, 1962 individuals
with ECG data and not included in ARIC were included in the
present analysis.
MESA. The Multi-Ethnic Study of Atherosclerosis (MESA) is
a population-based study of the characteristics of subclinical
cardiovascular disease that included 6,814 individuals (28%
African Americans) free from known cardiovascular disease
between 45–84 years recruited from 6 field centers in the US
[23]. Electrocardiographic recordings used in the present study
and blood sampling for DNA extraction were performed at
baseline visits between 2000–2002. African Americans constituted
28% of the total sample, of whom 1627 with genotype and
phenotype data remained after exclusions.
ECG recordings
12-lead electrocardiograms with standard lead placements were
recorded during ten seconds in all cohorts using Marquette MAC
PC, MAC6 or MAC1200 machines (GE Healthcare, Milwaukee,
WI, USA). PR interval duration was measured electronically using
either the Marquette 12SL algorithm or the MC MEANS
algorithm (Table S4).
Genotyping and quality control
All genotyping was performed at the Broad Institute of Harvard
and MIT using the Affymetrix Genome-Wide Human SNP Array
6.0, which interrogates 906,600 SNPs, according to the manufac-
turers recommendations. Sample processing and quality control
has been described previously [19] (Lettre G et al, submitted).
Briefly, 1 ug of genomic DNA was equally interleaved on 96-well
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master plates. Quantity of double stranded DNA was ascertained
using PicoGreen (Molecular Probes, Oregon, USA). Restriction
enzyme digestion and PCR amplification using universal primers
was performed to generate fragments of between 200–1,100 base
pairs in length which were further fragmented to 25–50 bp and
labeled with biotinylated nucleotides. Labeled fragments were
hybridized to the microarray, washed and detected. Genotypes
were called using Birdseed v1.33 and quality control steps were
performed in PLINK, EIGENSTRAT and PREST-Plus [24–28].
To confirm sample identity, genotype concordance between 24
SNPs genotyped in all samples both on the microarrays and using
Sequenom iPlex were monitored. DNA samples with genotyping
success rate ,95% were excluded. Autosomal heterozygosity rates
were estimated to identify and exclude samples with poor DNA
quality or contamination. Duplicated or contaminated samples
were identified from identity by descent (IBD) estimates and
excluded. Samples that were present in both JHS and ARIC were
excluded based on IBD concordance. We also excluded samples
unlikely to be African American (ARIC=8), based on principal
component analyses incorporating carefully curated reference
populations of 1,178 European Americans and 756 Nigerians in
EIGENSTRAT as previously described (Lettre G et al, submitted).
We excluded SNPs with genotyping success rate ,90%, minor
allele frequency ,1%, SNPs that map to multiple locations, SNPs
where missingness could be predicted from surrounding haplo-
types and SNPs associated with chemistry plates (i. e. differential
genotyping by plate). SNPs with unusually high numbers of
Mendelian errors were excluded from family-based samples. No
exclusions were performed based on Hardy-Weinberg equilibrium
given admixture of the sample. In total, about 800,000 SNPs
passed quality control in all cohorts.
Imputation and quality control
Imputation of additional ungenotyped SNPs was performed
using hidden Markov models as implemented in MACH v1.16
[29] for a total of 2,801,419 million SNPs. Phased reference
haplotypes from combined HapMap phase II CEU and YRI
panels were used with equal proportions. Imputation was
performed in two steps: in the first step, related individuals (as
identified by proportion of genomic variation shared IBS/IBD (pi
hat).0.05) were filtered and error and recombination rates were
estimated per sample in MACH using 30 iterations. In the second
step, estimated rates were used to estimate allele dosage for all
samples in one iteration. The average ratio of observed variance
over that expected under Hardy-Weinberg equilibrium per SNP
was also estimated as quality metric (R2). All samples were
genotyped for 50,000 SNPs using the ITMAT-Broad-CARe (IBC)
array [30] and the concordance rate (1–1/26 [imputed dosage –
chip dosage]) of imputed genotypes with IBC genotypes was high
(,95%) in all samples. We excluded poorly imputed SNPs (ratio of
observed over expected variance ,0.3), SNPs with minor allele
frequency,1% and non-autosomal SNPs. Sample outliers from
missingness clustering analyses in PLINK were also removed.
Phenotype modeling
We excluded from all analyses individuals with missing
covariates, ,18 years, pacemaker implant, Wolf-Parkinson-White
pattern, extreme PR values (,80 ms and .320 ms), prevalent
atrial fibrillation, heart failure, myocardial infarction, or 2nd or 3rd
degree AV block. PR interval duration was regressed linearly on
age, sex, RR interval, BMI, height, systolic blood pressure and
study site where relevant using SAS 9.2 (SAS Institute, Cary,
North Carolina). Residuals were used as phenotype for association
analyses.
Genome-wide association analyses and meta-analysis
For all cohorts except CFS, GWA analysis was performed in
PLINK, using a linear regression model with an additive genetic
model. The family-based CFS study was analyzed using linear
mixed-effects models as implemented in the GWAF package for R
[31]. Although JHS contains a family-based subcohort, little effect
on inflation of using family-based methods were observed in
preliminary analyses for a set of traits. Pedigrees for CFS were
confirmed using identity by state (IBS) or IBD estimates from
PREST-Plus. In all association analyses, we adjusted for
population stratification by including the first ten principal
components in addition to genome-wide SNP data. Cohort-
specific GWA results were combined using fixed effects meta-
analysis with inverse variance weights. Genomic inflation factors
were evaluated in each cohort prior to meta-analysis and in the
combined results [32]. We prespecified a genome-wide signifi-
cance threshold of 2.561028 as suggested for populations of
African ancestry by Pe’er et al [14], assuming 2 million
independent common variant tests in genomes of individuals of
African American ancestry with p,0.05 genome-wide. Heteroge-
neity across samples was assessed by Cochran’s x2 test of
heterogeneity with 4 degrees of freedom. To identify independent
signals at loci we clustered all genome-wide significant hits by
pairwise correlations$0.5 in the YRI HapMap panel. All analyses
were performed using PLINK or R version 2.10.1 (R Foundation
for Statistical Computing, Vienna, Austria). We examined the
results for any SNPs of genome-wide significance that were
uncorrelated with signals previously reported in other ancestral
populations in a large published GWA study of PR interval in
Europeans ancestry [8].
Genetic ancestry analyses
Individual estimates of global ancestry (proportion of European
ancestors relative to African ancestors) and local ancestry were
calculated using ANCESTRYMAP [33] and HAPMIX [34], as
previously described (Lettre G et al, submitted). To study the
association of genetic ancestry and PR interval, global ancestry
estimates were regressed linearly on PR residuals. To assess the
impact of local ancestry on SNP associations, all associations with
genome-wide significance were adjusted for local ancestry.
Supporting Information
Figure S1 Quantile-quantile plots for genome-wide association
studies of PR interval duration in African Americans.
Found at: doi:10.1371/journal.pgen.1001304.s001 (0.34 MB TIF)
Table S1 All SNPs reaching genome-wide significance
(p,2.561028) in a meta-analysis of four genome-wide association
studies of PR interval duration in African Americans. Positions
refer to NCBI build 36. Genomic control has been applied to
standard errors and p-values. SNP clusters as defined by r2 greater
than or equal to 0.5 are indicated. Neff refers to the effective
sample size, defined as N6R2, and reflects the loss of power with
poor imputation compared to the total sample sizes shown in
Table 1.
Found at: doi:10.1371/journal.pgen.1001304.s002 (0.07 MB
DOC)
Table S2 Imputation quality and effective sample size for the
SNPs with the lowest p-values in each linkage equilibrium bin of
genome-wide significant SNPs. R2 refers to the average ratio of
the observed variance over that expected under Hardy-Weinberg
equilibrium and indicates quality of imputation as poorly imputed
SNPs show less variability than expected based on allele frequency.
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Neff refers to the effective sample size, defined as N6R2, and
reflects the loss of power with poor imputation compared to the
total sample sizes shown in Table 1.
Found at: doi:10.1371/journal.pgen.1001304.s003 (0.03 MB
DOC)
Table S3 Conditional association analysis of the secondary
signal in SCN5A. Shown are association results for the SNP
rs6599222 in the SCN5A gene adjusted for the top SNP in the gene
(rs3922844).
Found at: doi:10.1371/journal.pgen.1001304.s004 (0.03 MB
DOC)
Table S4 Details on cohorts in the genome-wide association
analysis. * African American participants in ARIC were all
recruited at centers in Forsyth County, MS and Jackson, MS.
Individuals who participated in both JHS and ARIC were
excluded from JHS based on identity-by-descent estimates from
genome-wide data.
Found at: doi:10.1371/journal.pgen.1001304.s005 (0.03 MB
DOC)
Table S5 Details on replication cohorts. Mean and standard
deviations are presented for continuous variables and percentages
for categorical variables.
Found at: doi:10.1371/journal.pgen.1001304.s006 (0.04 MB
DOC)
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